Trials / Unknown
UnknownNCT03009643
Salvage Treatment of Inhaled Nitric Oxide in Patients With Refractory Hypoxemia After Aortic Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Shanghai Zhongshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hypoxemia is a common complication after aortic surgery. As this complication has an adverse effect on the postoperative course of the patient, early treatment is important; however, the mechanism of hypoxemia after surgery for acute aortic dissection remains unclear. Recently, the investigators found that inhaled Nitric Oxide can improve the oxygenation in some of these patients. The investigators are trying to evaluate the effectiveness and safety of inhaled Nitric Oxide in patients with refractory hypoxemia after aortic surgery.
Detailed description
Several risk factors for severe hypoxemia after aortic surgery have been reported including advanced age, obesity, smoking history, previous heart surgery,emergency surgery,reduced cardiac function, advanced chronic obstructive pulmonary disease, excessive volume of blood transfusion,and prolonged CPB time. The routine treatment includes lung protective mechanical ventilation, recruitment maneuvers and glucocorticoids. No previous clinical studies have reported the effectiveness and safety of inhaled Nitric Oxide in patients with refractory hypoxemia after aortic surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Inhaled Nitric Oxide | Patients are treated with iNO for 3-5 days.The concentration of inhaled Nitric Oxide is around 5-10ppm. |
| DEVICE | lung protective mechanical ventilation | Mechanical ventilation in the SIMV mode (ventilators Evita 2 or 4,Dräger, Lübeck, Germany) with VT 6-8ml/kg |
| DEVICE | Hemodynamic monitoring | Flotrac/Vigileo (Edwards Lifesciences) are used to guide the fluid management. |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2019-10-01
- Completion
- 2019-12-01
- First posted
- 2017-01-04
- Last updated
- 2018-02-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03009643. Inclusion in this directory is not an endorsement.